<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22063" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Gas Gangrene</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Buboltz</surname>
            <given-names>Jerome B.</given-names>
          </name>
          <aff>Aurora Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murphy-Lavoie</surname>
            <given-names>Heather M.</given-names>
          </name>
          <aff>University Medical Center, LSU Medical School</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jerome Buboltz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heather Murphy-Lavoie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22063.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Gas gangrene is a highly lethal infection of soft tissue caused by Clostridium species, with Clostridium perfringens being the most common. It is synonymous with myonecrosis and is characterized by rapidly progressive gangrene of the injured tissue and the production of foul-smelling gas. This activity explains the evaluation and management of gas gangrene and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of gas gangrene.</p></list-item><list-item><p>Assess&#x000a0;the evaluation of gas gangrene.</p></list-item><list-item><p>Evaluate the use of antibiotics, early surgical debridement, intravenous fluid resuscitation, ICU monitoring, and hyperbaric oxygen therapy in the management of gas gangrene.</p></list-item><list-item><p>Communicate the importance of collaboration among the interprofessional team to improve outcomes for patients affected by gas gangrene.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22063&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22063">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22063.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Gas gangrene is synonymous with myonecrosis and is a highly lethal infection of deep soft tissue caused by <italic toggle="yes">Clostridium</italic> species.&#x000a0;<italic toggle="yes">Clostridium perfringens</italic>&#x000a0;is&#x000a0;the most common (see <bold>Image.</bold> Gas Gangrene of a Diabetic Foot). <italic toggle="yes">Clostridial myonecrosis</italic> historically was a common war wound infection with an incidence of 5%. Still, with improvement in wound care, antisepsis, and the use of antibiotics, the incidence has fallen to 0.1% of war-related wound infections since the Vietnam War era. Puncture and surgical wounds, especially GI surgeries done on the biliary tract or intestinal surgeries, are causes of clostridial infections due to&#x000a0;inadvertent inoculation of the surgical wound with gut bacteria.<xref ref-type="bibr" rid="article-22063.r1">[1]</xref><xref ref-type="bibr" rid="article-22063.r2">[2]</xref></p>
      </sec>
      <sec id="article-22063.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Clostridial infections usually arise in traumatized tissue but also can arise spontaneously. The infection involves deeper tissue, such as a muscle, which can lead to a rapidly spreading infection along tissue planes, and patients often present with sepsis. The infection may develop hours to weeks after the initial trauma and inoculation. The inoculation of the bacteria does not always cause gas gangrene, and there are host and organism factors that determine the progression to infection. Immunocompromised patients and those with local tissue hypoxia (due to trauma or poor vascular supply) are most at risk. The most common organisms that cause these infections are C<italic toggle="yes">lostridium perfringens, Clostridium septicum,</italic> and <italic toggle="yes">Clostridium histolyticum</italic>. <italic toggle="yes">C. septicum</italic> is the most common cause of spontaneous gas gangrene associated with G.I. abnormalities, such as colon cancer. <italic toggle="yes">C. perfringens</italic> and <italic toggle="yes">C. histolyticum</italic> are more commonly associated with post-traumatic infections.<xref ref-type="bibr" rid="article-22063.r3">[3]</xref><xref ref-type="bibr" rid="article-22063.r4">[4]</xref></p>
        <p>More recently, in the literature, <italic toggle="yes">Clostridium sordellii</italic>, an uncommon pathogen, has been reported to cause fatal shock syndrome and gas gangrene of the uterus after medical abortion with oral mifepristone and vaginal&#x000a0;misoprostol. <italic toggle="yes">Clostridium sordellii</italic> is also on the rise associated with the use of black tar heroin injections, more commonly referred to as &#x0201c;popping.&#x0201d; This organism has&#x000a0;also had increased incidence as the cause of deep tissue infections associated with childbirth and infections after gynecologic procedures, including septic abortions, which can cause gas gangrene of the uterus.<xref ref-type="bibr" rid="article-22063.r1">[1]</xref><xref ref-type="bibr" rid="article-22063.r5">[5]</xref><xref ref-type="bibr" rid="article-22063.r6">[6]</xref></p>
      </sec>
      <sec id="article-22063.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In the United States, the incidence of myonecrosis is only about 1000 cases per year. The incidence is probably higher in less developed countries with decreased access to healthcare and antibiotics, but the exact number is unknown. With the best of care, including early recognition, surgical care, antibiotic treatment, and hyperbaric oxygen therapy, the overall mortality rate is 20% to 30% and, in some studies, as low as 5% to 10%; however, if not treated, the disease has a 100% fatality. Host factors such as an&#x000a0;immunocompromised state, diabetes mellitus, and spontaneous infections can have higher mortality rates of 67% or higher. If the infection involves the abdominal soft tissue or chest wall, the mortality rate can be as high as 60% compared to extremity infections with more favorable mortality of 5% to 30%.<xref ref-type="bibr" rid="article-22063.r7">[7]</xref><xref ref-type="bibr" rid="article-22063.r8">[8]</xref></p>
      </sec>
      <sec id="article-22063.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">C. perfringens</italic> causes 80% to 90% of gas gangrene cases, but other species can cause infection. In order of prevalence, they are<italic toggle="yes">&#x000a0;Clostridium novyi</italic> (40%), <italic toggle="yes">C. septicum</italic> (20%), <italic toggle="yes">C. histolyticum</italic> (10%), <italic toggle="yes">Clostridium bifermentans</italic> (10%), <italic toggle="yes">Clostridium fallax</italic> (5%), and <italic toggle="yes">C. sordellii</italic>.&#x000a0;These organisms are in the soil and organic waste, especially if contaminated with fecal material.</p>
        <p>Healthcare workers should suspect gas gangrene if anaerobic gram-positive bacilli are present in a wound with necrosis of soft tissue and muscle. The organisms produce a gas identifiable on X-ray or CT scans. Only about 5% of the wounds colonized with clostridial organisms develop an infection. Therefore, host factors and the anatomic location of the organism's injection help determine whether the bacteria develop into a clostridial myonecrosis infection. For example, a deep penetrating wound into muscle tissue where the host is immunocompromised is more likely to develop an infection than a host with a healthy immune system and good nutritional status. More open superficial wounds are less likely to become infected, especially if properly cleaned and dressed, compared to deeper penetrating wounds or wounds with crush injury and tissue ischemia.<xref ref-type="bibr" rid="article-22063.r9">[9]</xref></p>
        <p>The clostridial organisms produce alpha and theta toxins that cause extensive tissue damage. The infection can spread quickly, and within a matter of several hours, the patient may develop overwhelming shock, sepsis, and death. A better-oxygenated tissue with 70mmHg oxygen tension inhibits the organism's growth because clostridial species are facultative anaerobes.&#x000a0;A facultative anaerobe is an organism that makes ATP by aerobic respiration if oxygen is present but can switch to fermentation if oxygen is absent. If the oxygen tension of the tissue is less than 30 mm Hg, the clostridial organisms grow more quickly. The infection can develop slowly over weeks or rapidly over hours, depending on the oxygen tension of the tissue and the amount of organisms inoculated.<xref ref-type="bibr" rid="article-22063.r10">[10]</xref></p>
        <p>The virulence of the organism depends on the exotoxins produced; Clostridium perfringens is the most pathologic with 17 known toxins, with the most toxic being the alpha-toxin, a lecithinase. Alpha toxin is a phospholipase (lecithinase) that breaks down cell membranes, triggering platelet aggregation, thrombosis, and histamine release. Also present are collagenase, hyaluronidase, hemagglutinins, and hemolysins. Theta toxins cause direct vascular injury and breakdown of leukocytes, causing a blunted host inflammatory response to the infection. Collagenase breaks down connective tissue, allowing the organism to spread rapidly across tissue planes. This is&#x000a0;1 of the main reasons the infection can cross over connective tissue plains, spreading into the deeper muscle tissues.<xref ref-type="bibr" rid="article-22063.r5">[5]</xref><xref ref-type="bibr" rid="article-22063.r11">[11]</xref><xref ref-type="bibr" rid="article-22063.r12">[12]</xref></p>
      </sec>
      <sec id="article-22063.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><italic toggle="yes">Clostridium's Gram stain</italic>&#x000a0;shows&#x000a0;large gram-positive rods with a paucity of leukocytes (as is typical of anaerobic infections).</p>
      </sec>
      <sec id="article-22063.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Common toxins produced by <italic toggle="yes">C. perfringens</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alpha toxin: Lecithinase (or phospholipase) that breaks down cell membranes, resulting in cell death and tissue necrosis. This toxin is also hemolytic and cardiotoxic.</p>
          </list-item>
          <list-item>
            <p>Beta toxin: Necrosis of tissue</p>
          </list-item>
          <list-item>
            <p>Delta toxin: Hemolysin&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epsilon toxin: Acts to increase cell membrane permeability; permease.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Iota toxin: Necrosis of tissue</p>
          </list-item>
          <list-item>
            <p>Kappa toxin: Collagenase, gelatinase, and necrosis of tissue. It especially destroys blood vessels and connective tissue.</p>
          </list-item>
          <list-item>
            <p>Lambda toxin: Protease</p>
          </list-item>
          <list-item>
            <p>Mu toxin: Hyaluronidase</p>
          </list-item>
          <list-item>
            <p>Nu toxin: Deoxyribonuclease, hemolytic and necrosis of tissue&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Phi toxin: Hemolysin, cytolysin<xref ref-type="bibr" rid="article-22063.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22063.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with gas gangrene (myonecrosis) present with signs of infection such as fever, chills, pain, and less superficial inflammation at the site of infection than one would expect, given the deep penetrating nature of these infections. The condition of the patient can rapidly progress to sepsis and death if not treated aggressively.&#x000a0;The wound discharge is often dishwater-looking with a musty order. It can involve the vasculature that supplies large areas of infected tissue, leading to subcutaneous fat necrosis down to the fascia and extending into the deeper muscle. If the nerves are damaged, the severity of the pain is less than expected for the extent of infection. The drainage from the necrotic tissue often has a dishwater appearance and musty order. Signs of severe sepsis include septic shock, adult respiratory distress syndrome, disseminated intravascular coagulation, and hemolysis, which may cause hemolytic anemia, which is often how patients present.&#x000a0;Any&#x000a0;patient with a&#x000a0;cellulitis infection who develops&#x000a0;additional signs of crepitus&#x000a0;secondary to gas in the tissue and necrotic or dusky-looking skin should be&#x000a0;evaluated for gas gangrene.<xref ref-type="bibr" rid="article-22063.r14">[14]</xref><xref ref-type="bibr" rid="article-22063.r15">[15]</xref><xref ref-type="bibr" rid="article-22063.r16">[16]</xref></p>
      </sec>
      <sec id="article-22063.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Immediate workup of a patient with suspected gas gangrene includes CBC, CMP, urinalysis, PT, APTT, blood, and wound cultures. Additional blood tests such as ABG, lactic acid, and pre-calcitonin&#x000a0;can be helpful in the evaluation of sepsis, which is often present in gas gangrene. Common imaging studies include X-rays, CT scans of the infected body part, and ultrasound. These can help identify the extent of the infection, abscess, and gas in the tissues. See <bold>Image.</bold> Gas Gangrene. Extensive lab and imaging should not delay definitive surgical debridement of the necrotic tissue. During the initial surgical debridement, a deep-wound aerobic and anaerobic culture can help determine the causative organism and direct antibiotic therapy.<xref ref-type="bibr" rid="article-22063.r17">[17]</xref></p>
      </sec>
      <sec id="article-22063.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Because the infection is rapidly progressive, it is important to treat patients aggressively with antibiotics, early surgical consultation with debridement, intravenous fluid resuscitation, ICU monitoring, and adjuvant hyperbaric oxygen therapy. Getting early surgical consultation without delay is important as this is a true surgical emergency. Providers should not delay antibiotics to get cultures but begin empiric treatment with antibiotics. Reasonable broad-spectrum coverage includes vancomycin, tazobactam, a carbapenem, or ceftriaxone with metronidazole. If the provider suspects gas gangrene or a necrotizing soft tissue infection, penicillin plus clindamycin should be added, which treats group A streptococcal necrotizing fasciitis. Clindamycin should be strongly considered because it inhibits the synthesis of clostridial exotoxins and lessens the systemic effects of these toxins. Because clindamycin is bacteriostatic and not bactericidal, it should be used with a second anti-microbial, such as penicillin.<xref ref-type="bibr" rid="article-22063.r18">[18]</xref><xref ref-type="bibr" rid="article-22063.r19">[19]</xref><xref ref-type="bibr" rid="article-22063.r20">[20]</xref><xref ref-type="bibr" rid="article-22063.r21">[21]</xref><xref ref-type="bibr" rid="article-22063.r22">[22]</xref></p>
        <p>Fasciotomy&#x000a0;may be necessary to relieve compartment pressures. As the infection progresses into deep tissue along and under the fascia, compartment pressures increase, perpetuating further tissue ischemia and necrosis. Surgical debridement should focus on removing all the necrotic tissue and foreign bodies, such as soil, debris, and shrapnel. Irrigating the wounds with copious amounts of sterile normal saline is also important. Hyperbaric oxygen therapy should be added to standard antibiotics and surgical debridement therapy to help improve survival.<xref ref-type="bibr" rid="article-22063.r22">[22]</xref><xref ref-type="bibr" rid="article-22063.r23">[23]</xref> It is important to have coordinated care of these critically ill patients with an intensivist, general surgeon, orthopedic surgeon, urologist (in the setting of Fournier&#x02019;s gangrene of the testicles and perineal structures), gynecologist (in the setting of uterine gas gangrene), infectious&#x000a0;disease specialist, hematologist/oncologist, gastroenterologist (in the setting of spontaneous gas gangrene), and hyperbaric&#x000a0;oxygen therapy specialist. The consultation flow usually starts with an emergency department provider and early disease recognition.<xref ref-type="bibr" rid="article-22063.r24">[24]</xref><xref ref-type="bibr" rid="article-22063.r25">[25]</xref><xref ref-type="bibr" rid="article-22063.r24">[24]</xref></p>
        <p>Early IV antibiotics with early surgical debridement followed by hyperbaric oxygen therapy can salvage patients with an otherwise nearly always fatal disease. Intravenous antibiotics and early surgical debridement of the necrotic tissue reduce the fatality rate&#x000a0;to about 30%. Hyperbaric oxygen therapy can reduce this to 5 to 10%. Hyperbaric oxygen therapy helps by halting exotoxin production by the bacteria, helps to improve the bactericidal&#x000a0;effect of the antibiotic, treats the tissue ischemia, improves reperfusion injury of the tissue, and promotes the activation and migration of stem cells and polymorphonuclear cells. Additionally, hyperbaric oxygen induces vasoconstriction, reducing tissue edema while augmenting oxygenation. The oxygen tension of the tissue increases by a factor of 1000, and this increased oxygen in the tissue helps to resolve hypoxia, improve cellular activity, inhibit bacterial growth, and affect cytokinesis, which increases the migration of neutrophils to the injured tissue. Hyperbaric oxygen&#x000a0;also increases the production of growth factors such as vascular epidermal growth factor, which induces neovascularization and tissue repair with capillary budding. This is recognized clinically as increased granulation tissue formation and is usually seen after several hyperbaric oxygen treatments.<xref ref-type="bibr" rid="article-22063.r26">[26]</xref><xref ref-type="bibr" rid="article-22063.r27">[27]</xref><xref ref-type="bibr" rid="article-22063.r28">[28]</xref><xref ref-type="bibr" rid="article-22063.r27">[27]</xref></p>
        <p>Hyperbaric oxygen therapy involves placing the patient in a pressurized chamber, which can be mono-place (single patient) or multi-place (multiple patients treated simultaneously). The mono-place chamber can only treat&#x000a0;1 patient at a time, and the attendant is outside the chamber with specialized equipment and pumps to run IVs and even mechanical ventilation&#x000a0;equipment through ports in the chamber door or wall. The disadvantage of this setup is that it limits the therapies available in the chamber. If the patient requires direct contact with the attendant, the chamber has to be depressurized, and the patient is taken out of the chamber. The multi-place chamber has the added benefit of being able to treat multiple patients at the same time,&#x000a0;and the attendant is in the chamber with the patients, allowing easier access to the patient for ventilator support, IV therapy, placement of a chest tube, or needle decompression of a pneumothorax. The treatment pressure for gas gangrene is 3 atmospheres absolute. The patient has air brakes every half hour to help reduce the risk of oxygen toxicity. These air brakes are usually 5 to 10 minutes in duration. The treatment at pressure is usually about 90 minutes, with 10 minutes for descent and 10 minutes for the ascent.<xref ref-type="bibr" rid="article-22063.r24">[24]</xref><xref ref-type="bibr" rid="article-22063.r29">[29]</xref><xref ref-type="bibr" rid="article-22063.r30">[30]</xref><xref ref-type="bibr" rid="article-22063.r24">[24]</xref></p>
        <p>When treating gas gangrene, the treatments start twice a day for the first 5 to 10 treatments, reducing to once-daily treatments when stabilized. Continuing hyperbaric oxygen therapy beyond the initial stabilization can speed tissue healing and preparation for eventual tissue grafting, often necessary to close the large defects left after surgical debridement of dead tissue. The risk of hyperbaric oxygen therapy includes oxygen toxicity, which can cause seizures, hypoglycemia, especially in insulin-dependent diabetics, and barotrauma, which can affect the ears, lungs, or any gas-filled structures, such as the stomach, and gas embolism. These complications are rare, except for ear barotrauma, which occurs approximately 43% of the time (84% of these are minor injections of the tympanic membrane).&#x000a0;</p>
        <p>It is crucial to get early surgical consultation without delay in the case of gas gangrene, as this is an immediate emergency. Broad-spectrum antibiotics should be initiated without any delay in getting cultures. Reasonable coverage should include vancomycin, tazobactam, or a carbapenem, or a third-generation cephalosporin (ceftriaxone) with metronidazole. Moreover, in case of any suspicion of gas gangrene or necrotizing fascitis, penicillin plus clindamycin should be added to cover group A streptococcal necrotizing fasciitis. Clindamycin is strongly recommended. Adjunctive measures in the treatment of gas gangrene include hyperbaric oxygen (HBO) therapy. The function of the existing toxin is not affected by hyperbaric oxygen therapy; thus, debridement is of paramount importance. Hemodynamically unstable patients may not be candidates for HBO therapy. Moreover, animal experimental studies in animals failed to document the therapeutic efficacy of HBO.<xref ref-type="bibr" rid="article-22063.r31">[31]</xref><xref ref-type="bibr" rid="article-22063.r32">[32]</xref><xref ref-type="bibr" rid="article-22063.r23">[23]</xref>&#x000a0;Providers should consider using negative pressure wound dressing therapy once adequate surgical debridement has resolved ongoing tissue necrosis.</p>
      </sec>
      <sec id="article-22063.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential for gas gangrene includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abdominal abscess</p>
          </list-item>
          <list-item>
            <p>Abdominal trauma</p>
          </list-item>
          <list-item>
            <p>Bacteria sepsis</p>
          </list-item>
          <list-item>
            <p>Elective abortion</p>
          </list-item>
          <list-item>
            <p>Emphysematous cholecystitis</p>
          </list-item>
          <list-item>
            <p>Group A streptococcal infections</p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Toxic shock syndrome</p>
          </list-item>
          <list-item>
            <p>Vibrio infection<xref ref-type="bibr" rid="article-22063.r33">[33]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22063.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Patients with gas gangrene need daily or repeated surgical debridement until the necrotizing infection is controlled and receive twice-daily hyperbaric oxygen therapy until tissue necrosis stops and signs of tissue recovery with granulation tissue formation occur. The patient also needs ongoing intensive care and may require hemodialysis for renal failure and extracorporeal membrane oxygenation for patients with severe&#x000a0;adult respiratory distress syndrome. Once the infection resolves, many patients require further wound care, often with negative pressure wound therapy, advanced tissue regeneration techniques, and plastic surgical therapies such as skin grafting and flap procedures to close the surgical wounds. Many patients with gas gangrene required prolonged ICU stays, followed by long rehab to improve survival and restore function. Many patients require transfer to a long-term care facility for ongoing wound care, sometimes hyperbaric oxygen therapy, and therapeutic rehab programs with physical therapy and occupational therapy.<xref ref-type="bibr" rid="article-22063.r34">[34]</xref><xref ref-type="bibr" rid="article-22063.r35">[35]</xref></p>
      </sec>
      <sec id="article-22063.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>To enhance patient survival and reduce morbidity in gas gangrene, this diagnosis should be high on the differential if the patient presents with infection with signs of necrotic tissue, sepsis, or if gas is present in the tissue. It is important to diagnose early, consult surgery for emergent debridement, and transfer patients with gas gangrene to facilities that have the capability of taking care of such ill patients. They require coordinated care between surgery, intensive care, and hyperbaric oxygen/wound care.<xref ref-type="bibr" rid="article-22063.r36">[36]</xref><xref ref-type="bibr" rid="article-22063.r37">[37]</xref></p>
      </sec>
      <sec id="article-22063.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Best outcomes are achieved with coordinated care between multiple specialties and intensive care in a facility with personnel competent in caring for critically ill patients. Care has to be coordinated between the surgeons doing the debridements, the wound care/hyperbaric oxygen providers, and the intensivist. Photo documentation in the electronic health record helps improve coordination of care. The surgical team can take pictures in the operating room, and the wound care team can also take pictures when doing dressing changes.&#x000a0;This helps nurses and other specialties, such as plastic surgery and infectious disease, know the progress and helps guide decisions. Rehabilitation should start as soon as the patient can, reducing the risk of blood clots and muscle atrophy. The care team effort must be coordinated&#x000a0;so that everyone is on the same page regarding expectations of outcomes. There needs to be peer review and evaluation of team performance for the improvement of patient care&#x000a0;in a non-hostile and supportive manner so that all team members are able and willing to contribute to improved patient care.<xref ref-type="bibr" rid="article-22063.r14">[14]</xref><xref ref-type="bibr" rid="article-22063.r38">[38]</xref><xref ref-type="bibr" rid="article-22063.r39">[39]</xref></p>
      </sec>
      <sec id="article-22063.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22063&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22063">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/gas-gangrene/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22063">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22063/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22063">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22063.s16">
        <fig id="article-22063.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Gas Gangrene of a Diabetic Foot Contributed by H Murphy-Lavoie, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gas__gangrene" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22063.s17">
        <fig id="article-22063.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Gas Gangrene. Plain x-ray showing gas in the tissue planes in a patient with gas gangrene. &#x00634;&#x006c1;&#x00627;&#x00628;,<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?search=gas+gangrene+x-ray&#x00026;title=Special:MediaSearch&#x00026;go=Go&#x00026;type=image"> Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gas__Gangrene" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22063.s18">
        <title>References</title>
        <ref id="article-22063.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takehara</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Host Defense against Bacterial Infection and Bacterial Toxin-induced Impairment of Innate Immunity].</article-title>
            <source>Yakugaku Zasshi</source>
            <year>2018</year>
            <volume>138</volume>
            <issue>10</issue>
            <fpage>1249</fpage>
            <page-range>1249-1253</page-range>
            <pub-id pub-id-type="pmid">30270267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Aldape</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Life-threatening clostridial infections.</article-title>
            <source>Anaerobe</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>254</fpage>
            <page-range>254-9</page-range>
            <pub-id pub-id-type="pmid">22120198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>IW</given-names>
              </name>
            </person-group>
            <article-title>Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene.</article-title>
            <source>J Foot Ankle Res</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">29312468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perkins</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Bieniek</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sumfest</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Solitary Candida albicans Infection Causing Fournier Gangrene and Review of Fungal Etiologies.</article-title>
            <source>Rev Urol</source>
            <year>2014</year>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">25009452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dempsey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Serious infection associated with induced abortion in the United States.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>888</fpage>
            <page-range>888-92</page-range>
            <pub-id pub-id-type="pmid">23090457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing Soft-Tissue Infections.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>377</volume>
            <issue>23</issue>
            <fpage>2253</fpage>
            <page-range>2253-2265</page-range>
            <pub-id pub-id-type="pmid">29211672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shindo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dobashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Monma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miyatani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological and pathobiological profiles of Clostridium perfringens infections: review of consecutive series of 33 cases over a 13-year period.</article-title>
            <source>Int J Clin Exp Pathol</source>
            <year>2015</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>569</fpage>
            <page-range>569-77</page-range>
            <pub-id pub-id-type="pmid">25755747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehnhardt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Homann</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Daigeler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Steinau</surname>
                <given-names>HU</given-names>
              </name>
            </person-group>
            <article-title>Major and lethal complications of liposuction: a review of 72 cases in Germany between 1998 and 2002.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>121</volume>
            <issue>6</issue>
            <fpage>396e</fpage>
            <page-range>396e-403e</page-range>
            <pub-id pub-id-type="pmid">18520866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takazawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Otsuka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inokuchi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features of Non-clostridial Gas Gangrene and Risk Factors for In-hospital Mortality.</article-title>
            <source>Tokai J Exp Clin Med</source>
            <year>2015</year>
            <month>Sep</month>
            <day>20</day>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>124</fpage>
            <page-range>124-9</page-range>
            <pub-id pub-id-type="pmid">26369267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janik</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ceremuga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saluk-Bijak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bijak</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Biological Toxins as the Potential Tools for Bioterrorism.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Mar</month>
            <day>08</day>
            <volume>20</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30857127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Srivastava</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aldape</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous C.&#x000a0;septicum gas gangrene: A literature review.</article-title>
            <source>Anaerobe</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>48</volume>
            <fpage>165</fpage>
            <page-range>165-171</page-range>
            <pub-id pub-id-type="pmid">28780428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crum-Cianflone</surname>
                <given-names>NF</given-names>
              </name>
            </person-group>
            <article-title>Infection and musculoskeletal conditions: Infectious myositis.</article-title>
            <source>Best Pract Res Clin Rheumatol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>1083</fpage>
            <page-range>1083-97</page-range>
            <pub-id pub-id-type="pmid">17127198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carter</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Larcombe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lyras</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Regulation of toxin production in the pathogenic clostridia.</article-title>
            <source>Mol Microbiol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-31</page-range>
            <pub-id pub-id-type="pmid">24563915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Aggressive Soft Tissue Infections.</article-title>
            <source>Surg Clin North Am</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>1097</fpage>
            <page-range>1097-1108</page-range>
            <pub-id pub-id-type="pmid">30243450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Martucci</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The Unusual Presence of Gas From a Puncture Wound: A Case Report.</article-title>
            <source>J Foot Ankle Surg</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>785</fpage>
            <page-range>785-789</page-range>
            <pub-id pub-id-type="pmid">29571810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cristoferi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fabris</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ronconi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bozza</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gallassi</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Bucca</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Caria</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Duodeci</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Gas gangrene. Clinical considerations, prognosis and therapeutic prospects in our experience].</article-title>
            <source>J Chir (Paris)</source>
            <year>1991</year>
            <month>May</month>
            <volume>128</volume>
            <issue>5</issue>
            <fpage>243</fpage>
            <page-range>243-6</page-range>
            <pub-id pub-id-type="pmid">1880179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarvari</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Vasas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kiss</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Horvath</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Urban</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Fatal Clostridium perfringens sepsis due to emphysematous gastritis and literature review.</article-title>
            <source>Anaerobe</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>40</volume>
            <fpage>31</fpage>
            <page-range>31-4</page-range>
            <pub-id pub-id-type="pmid">27036998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finsterer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Neuromuscular and central nervous system manifestations of Clostridium perfringens infections.</article-title>
            <source>Infection</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>396</fpage>
            <page-range>396-405</page-range>
            <pub-id pub-id-type="pmid">18034207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nichols</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Anaerobes from a surgical perspective.</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>May</month>
            <volume>18 Suppl 4</volume>
            <fpage>S280</fpage>
            <page-range>S280-6</page-range>
            <pub-id pub-id-type="pmid">8086576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>YG</given-names>
              </name>
            </person-group>
            <article-title>Vacuum-Assisted Closure (VAC) Using Multiple Foam Pieces for Hidden Space Drainage through Less Exposure in Musculoskeletal Infections.</article-title>
            <source>J Hand Surg Asian Pac Vol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>369</fpage>
            <page-range>369-376</page-range>
            <pub-id pub-id-type="pmid">30282543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Leng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Interventions for treating gas gangrene.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Dec</month>
            <day>03</day>
            <volume>2015</volume>
            <issue>12</issue>
            <fpage>CD010577</fpage>
            <pub-id pub-id-type="pmid">26631369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devaney</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Frawley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frawley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pilcher</surname>
                <given-names>DV</given-names>
              </name>
            </person-group>
            <article-title>Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality.</article-title>
            <source>Anaesth Intensive Care</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>685</fpage>
            <page-range>685-92</page-range>
            <pub-id pub-id-type="pmid">26603791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Clostridial myonecrosis (gas gangrene).</article-title>
            <source>Undersea Hyperb Med</source>
            <year>2012</year>
            <season>May-Jun</season>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>731</fpage>
            <page-range>731-7</page-range>
            <pub-id pub-id-type="pmid">22670554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathieu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marroni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kot</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment.</article-title>
            <source>Diving Hyperb Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-32</page-range>
            <pub-id pub-id-type="pmid">28357821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gacto-Sanchez</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment and management of the severely burn patient: Review and update.</article-title>
            <source>Med Intensiva</source>
            <year>2017</year>
            <season>Aug-Sep</season>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>356</fpage>
            <page-range>356-364</page-range>
            <pub-id pub-id-type="pmid">28456441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pruskowski</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.</article-title>
            <source>Surg Infect (Larchmt)</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">33164665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cornistein</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cerino</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Nacif</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Systemic antimicrobial prophylaxis in burn patients: systematic review.</article-title>
            <source>J Hosp Infect</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-114</page-range>
            <pub-id pub-id-type="pmid">28629932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramundo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Garritano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Durante</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene during lenvatinib treatment: A case report.</article-title>
            <source>Mol Clin Oncol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>588</fpage>
            <page-range>588-591</page-range>
            <pub-id pub-id-type="pmid">32337042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chantre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Foucher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Le Hot</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lefort</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Blatteau</surname>
                <given-names>J&#x000c9;</given-names>
              </name>
            </person-group>
            <article-title>[Hyperbaric oxygen therapy, a little-known discipline].</article-title>
            <source>Rev Infirm</source>
            <year>2018</year>
            <season>Jun-Jul</season>
            <volume>67</volume>
            <issue>242</issue>
            <fpage>14</fpage>
            <page-range>14-15</page-range>
            <pub-id pub-id-type="pmid">29907169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burman</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Low-pressure fabric hyperbaric chambers.</article-title>
            <source>S Afr Med J</source>
            <year>2019</year>
            <month>Mar</month>
            <day>29</day>
            <volume>109</volume>
            <issue>4</issue>
            <fpage>12574</fpage>
            <pub-id pub-id-type="pmid">31084683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyboer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric Oxygen Therapy Side Effects - Where Do We Stand?</article-title>
            <source>J Am Coll Clin Wound Spec</source>
            <year>2016</year>
            <volume>8</volume>
            <issue>1-3</issue>
            <fpage>2</fpage>
            <page-range>2-3</page-range>
            <pub-id pub-id-type="pmid">30276115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections.</article-title>
            <source>Respir Care Clin N Am</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-19</page-range>
            <pub-id pub-id-type="pmid">10333449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chernyadyev</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ufimtseva</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vishnevskaya</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Bochkarev</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ushakov</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Beresneva</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Galimzyanov</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Khodakov</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Literature Review and Clinical Cases.</article-title>
            <source>Urol Int</source>
            <year>2018</year>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-97</page-range>
            <pub-id pub-id-type="pmid">29949811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Fournier gangrene: a review of 41 patients and strategies for reconstruction.</article-title>
            <source>Ann Plast Surg</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>765</fpage>
            <page-range>765-9</page-range>
            <pub-id pub-id-type="pmid">20407363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGinness</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kurtz Phelan</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Use of Viable Cryopreserved Umbilical Tissue for Soft Tissue Defects in Patients With Gas Gangrene: A Case Series.</article-title>
            <source>Wounds</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>90</fpage>
            <page-range>90-95</page-range>
            <pub-id pub-id-type="pmid">29718818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ingraham</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Liepert</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Warner-Hillard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Scarborough</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Effect of transfer status on outcomes for necrotizing soft tissue infections.</article-title>
            <source>J Surg Res</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>220</volume>
            <fpage>372</fpage>
            <page-range>372-378</page-range>
            <pub-id pub-id-type="pmid">29180205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mills</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Faraklas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stoddard</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Saffle</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Outcomes from treatment of necrotizing soft-tissue infections: results from the National Surgical Quality Improvement Program database.</article-title>
            <source>Am J Surg</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>200</volume>
            <issue>6</issue>
            <fpage>790</fpage>
            <page-range>790-6; discussion 796-7</page-range>
            <pub-id pub-id-type="pmid">21146022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roloff</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Prerequisites for the transfer of patients with gas gangrene to a specialized facility].</article-title>
            <source>Anaesthesiol Reanim</source>
            <year>1991</year>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-58</page-range>
            <pub-id pub-id-type="pmid">2043237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22063.r39">
          <label>39</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sison-Martinez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hendriksen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <chapter-title>Hyperbaric Treatment of Clostridial Myositis and Myonecrosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">29763178</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
